Please ensure Javascript is enabled for purposes of website accessibility
Collegium Pharmaceutical Stock Quote

Collegium Pharmaceutical (NASDAQ: COLL)

Price as of June 2, 2023, 3:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Collegium Pharmaceutical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
COLL +38.03% -11.24% -2.35% +76%
S&P +2.53% +56.60% +9.37% +105%

Collegium Pharmaceutical Company Info

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.